InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
79.75
(
0.00%
)
Bitcoin
68,068.60
(
0.39%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: None

Monday, 01/28/2008 7:17:57 PM

Monday, January 28, 2008 7:17:57 PM

Post# of 4764
FYI--Interesting Motley Fool comment regarding the AMGN purchase of ABGX. The article below states that the elimination of denosumab royalties was the MAIN reason for the AMGN purchase of ABGX. Several posters here have cited this as the reason. However, this is the first time that I have seen this opinion directly stated in the financial press.

http://www.fool.com/investing/high-growth/2008/01/28/a-wing-and-a-prayer-for-amgen.aspx
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up